GLOBAL VALUE SELECTION FI

Leaves the portfolio; it was 10.16% of weight.

Leaves the portfolio; it was 1.48% of weight.

Leaves the portfolio; it was 1.47% of weight.

UBS Group AG operates as a wealth manager and bank worldwide. It operates through five segments: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-Core and Legacy. The Global Wealth Management segment offers financial services, advice, and solutions; investment management, estate planning, and corporate advice services; and wealth management and banking products and services to private wealth and institutional customers. Its Personal & Corporate Banking segment provides banking, retirement, financing, investments, and strategic transactions to private, corporate, and institutional customers through its branch network and digital channels in Switzerland. The Asset Management segment offers diversified asset management services. Its Investment Bank segment provides equities, foreign exchange, precious metals, research, advisory, and capital markets services to institutional, corporate, financial sponsor, and Global Wealth Management customers, as well as focused rates and credit platform. The company also offers lending products, such as securities-based lending, mortgages, structured products, and tailored solutions; collateralized lending residential and commercial real estate, primarily against securities, residential and commercial real estate, other real assets (such as ships and aircraft), private market and hedge fund interest; and unsecured lending. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is headquartered in Zurich, Switzerland.

Leaves the portfolio; it was 1.19% of weight.

Leaves the portfolio; it was 0.74% of weight.

Gestamp Automoción, S.A. designs, develops, and manufactures metal components for the automotive industry in Western Europe, Eastern Europe, Mercosur, North America, and Asia. The company offers body-in-white products, large components and assembly parts, such as bonnets, roofs, doors, and mudguards, as well as other surface and assembly parts for use in creation of visible exterior skin of vehicles; and structural and crash-related elements, including floors, pillars, rails, and wheel arches. It also provides chassis parts comprising under body of vehicles and includes systems, frames and related parts, such as front and rear axles and couplings, control arms, and integrated couplings; hinges, door checks, electrical systems, and powered systems. In addition, the company offers hydraulic presses and dies in the areas of hot stamping, cold stamping, hydroforming, and try out of tools. Further, it serves vehicle manufacturers. Gestamp Automoción, S.A. was incorporated in 1997 and is headquartered in Madrid, Spain. Gestamp Automoción, S.A. is a subsidiary of Gestamp 2020, S.L.

Leaves the portfolio; it was 0.74% of weight.

Aedas Homes, S.A. engages in the development of residential properties in Spain. The company focuses on single-family homes; provides real estate services; and decoration and interior design services, as well as develop turnkey build-to-rent properties. It serves individuals and institutional investors. The company was founded in 2016 and is headquartered in Madrid, Spain. Aedas Homes, S.A. operates as a subsidiary of Neinor Homes, S.A.

Leaves the portfolio; it was 0.74% of weight.

Fomento de Construcciones y Contratas, S.A., together with its subsidiaries, provides environmental services in Europe and internationally. It operates through Environmental Services; Integrated Water Management; Construction; Concessions; Cement; and Real Estate segments. The company offers municipal, waste treatment and resource recycling, and facility management services; and concessions and proprietary infrastructure for the entire cycle, BOT, operation and maintenance services, and irrigation, as well as technology and network activities, which include EPC contracts and industrial water treatment activities; design, planning, construction, and maintenance services. It also engages in developing, financing, managing, and operating social and transportation infrastructure concessions. The company was formerly known as Fomento de Obras y Construcciones S.A. and changed its name to Fomento de Construcciones y Contratas, S.A. in January 1992. Fomento de Construcciones y Contratas was founded in 1900 and is headquartered in Madrid, Spain. The company operates as a subsidiary of Control Empresarial de Capitales SA de CV.

Leaves the portfolio; it was 0.72% of weight.

Leaves the portfolio; it was 0.45% of weight.

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Leaves the portfolio; it was 0.44% of weight.

ArcelorMittal S.A., together with its subsidiaries, operates as integrated steel and mining companies in the Americas, Europe, Asia, and Africa. It offers semi-finished flat products, including slabs; finished flat products comprising plates, hot- and cold-rolled coils and sheets, hot-dipped and electro-galvanized coils and sheets, tinplate, and color coated coils and sheets; semi-finished long products, such as blooms and billets; finished long products consisting of bars, wire-rods, structural sections, rails, sheet piles, and wire-products; and seamless and welded pipes and tubes. The company also provides mining products, such as iron ore lumps, fines, concentrate, pellets, and sinter feeds; and coking coal. It sells its products to various customers in the automotive, appliance, engineering, construction, energy, and machinery industries through a centralized marketing organization, and distributors. The company operates iron ore mining activities in Brazil, Bosnia, Liberia, Mexico, South Africa, and Ukraine, as well as in India and in Canada. ArcelorMittal S.A. was founded in 1976 and is headquartered in Luxembourg, Luxembourg.

Leaves the portfolio; it was 0.30% of weight.

Leaves the portfolio; it was 0.17% of weight.

Endesa, S.A. engages in the generation, distribution, and sale of electricity in Spain, Portugal, France, Germany, the United Kingdom, Switzerland, Luxembourg, the Netherlands, Singapore, Italy, Morocco, and internationally. It generates electricity from various energy sources, such as hydroelectric, nuclear, thermal, wind, and solar. The company also offers advisory services and technology relating to energy, distributed generation, and energy demand management; deploys infrastructures for charging electric vehicles, vehicle-to-grid, and second-life services for batteries; develops integrated services for local administrations, such as public lighting, smart city development, energy services, and solutions for connectivity; and provides financial solutions for energy producers, as well as offers engineering and construction services for facilities related to the electricity business. As of December 31, 2025, it had an installed capacity of 22, 616 MW; operated 321,843 km of distribution networks and transmission grids; and distributed electricity to 9,590 thousand customers and gas to 1,699 thousand customers. The company was formerly known as Empresa Nacional de Electricidad, S.A. and changed its name to Endesa, S.A. in June 1997. The company was incorporated in 1944 and is headquartered in Madrid, Spain. Endesa, S.A. is a subsidiary of Enel Iberia Srl.

Leaves the portfolio; it was 0.11% of weight.

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon to prevent pregnancy; Follistim AQ, which is used to promote development of ovarian follicles; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding and hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; oncology products, including Ontruzant and Aybintio; Bildyos and Bilprevda, a recombinant anti-RANKL human monoclonal antibodies; and Poherdy, a neu receptor antagonist. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products to control and prevent asthma symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company serves drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey.

Goes from 0.79% to 0.32%.

Repsol, S.A. operates as a multi-energy company in Spain, Peru, the United States, Portugal, and internationally. The Upstream segment engages in the exploration, development, and production of crude oil and natural gas reserves; and development of low-carbon geological solutions. Its Industrial segment is involved in oil refining; trading, transport, and wholesale of crude oil, natural gas, and fuels; and activities related to hydrogen, sustainable biofuels, and synthetic fuels. The Customer segment engages in the mobility/gas station business; and sale of electricity and gas, lubricants, and other products, as well as fuel products, such as gasoline, diesel, aviation kerosene, liquefied petroleum gas, and biofuels. Its Low-Carbon Generation segment is involved in electricity generation from hydroelectric, wind, and photovoltaic sources. The company also engages in financial services; sector studies; human resources and shared services; decarbonization; carbon dioxide capture and pyrolysis HUB pilot plants; development of production processes, storage, transport, use, consumption, and transformation of hydrogen; promotion, design, construction, and operation of molecular recycling facilities; and production of chemical and petrochemical products. In addition, it is involved in waste management; construction and operation of oil refinery; research; electricity distribution; maritime transport and inland waterways; LNG regasification; investment in liquefaction plant; safety; electric vehicle charging points; customer and oil product marketing management; payment management at gas stations; development of greenfield and new energy projects; and insurance and reinsurance activities. Further, the company offers various apps and tools, such as Waylet, Vivit, and WiBLE; and asphalt products. The company was formerly known as Repsol YPF, S.A. and changed its name to Repsol, S.A. in May 2012. Repsol, S.A. was founded in 1927 and is headquartered in Madrid, Spain.

Goes from 0.63% to 0.23%.

Smurfit Westrock Plc, together with its subsidiaries, manufactures, distributes, and sells containerboard, corrugated containers, and other paper-based packaging products in North America, South America, Europe, Asia, Africa, Australia, and internationally. The company produces containerboard and paperboard; packaging of corrugated containers; consumer packaging; and offers solid board, kraft paper, and graphic board, as well as other packaging products, such as solidboard packaging, paper sacks and bag-in-box. It produces linerboard and corrugated medium and paperboard; and other paper-based packaging, such as folding cartons, inserts, labels and displays. The company primarily serves food and beverage, healthcare, beauty and personal care, garden, consumer goods, industrial, and foodservice markets. It markets its products through its own sales force, independent sales representatives, and independent distributors. Smurfit Westrock Plc was founded in 1934 and is headquartered in Dublin, Ireland.

Leaves the portfolio; it was 1.47% of weight.

Leaves the portfolio; it was 0.74% of weight.